Trial intelligence / Profile preview

Pentoxifylline for treatment of Covid-19

IRCT20110425006280N11Phase 2Completed

Sponsor
Guilan University of Medical Sciences
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of pentoxifylline in coronavirus disease 2019 (COVID-19), sponsored by Guilan University of Medical Sciences. Started Jan 2021; status: completed.

02

Drugs

pentoxifylline
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20110425006280N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20110425006280N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call